Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03673228Completed
Randomised, open-label trial (2 arms), sponsored by NYU Langone Health. Primary endpoint: Self Reported Relapse Rate at 12 months. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03673228.